HIGH

Heraeus Medical Recalls PALACOS Bone Cement Due to Ampoule Breakage Hazard

Heraeus Medical GmbH recalled PALACOS R+G pro 40 and 80 bone cements on December 9, 2025. The recall follows multiple reports of ampoule breakage that prevent proper use of the product. Patients and healthcare providers must stop using the affected devices immediately.

Quick Facts at a Glance

Recall Date
December 9, 2025
Hazard Level
HIGH
Brand
Heraeus Medical GmbH
Category
Health & Personal Care
Sold At
Multiple Retailers
At-Risk Groups
GENERAL

Hazard Information

increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule breakage. An unfortunate combination of these influence factors can lead to unbreakable ampoules. If none or not all ampoules break, the product cannot be used on the patient since no or no appropriate cement dough is formed.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Heraeus Medical GmbH (Dental Division) or your healthcare provider for instructions. Notification method: E-Mail

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall affects PALACOS R+G pro 40 (Model 5081288) and PALACOS R+G pro 80 (Model 5081289) bone cements. These products are radiopaque, poly(methyl methacrylate)-based bone cements. They were distributed internationally, including countries such as Australia, Belgium, and the United Kingdom.

The Hazard

Reports indicate an increase in complaints regarding ampoule breakage within the device systems. If none or not all ampoules break, the product cannot be used, leading to potential complications in medical procedures.

Reported Incidents

There have been multiple incidents reported, though no specific injury or death counts are available. The ampoule breakage can lead to the product being unusable, posing a high-risk factor for patients.

What to Do

Stop using the affected bone cement immediately. Contact Heraeus Medical GmbH or your healthcare provider for instructions on the recall process.

Contact Information

For more information, contact Heraeus Medical GmbH. Visit the official website or send an email as per the recall instructions.

Key Facts

  • Models affected: 5081288, 5081289
  • Class II medical device
  • International distribution
  • Stop using the product immediately

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
Lot Code: UDI-DI: 04260102136182
04260102136212
Report Date
January 21, 2026
Recall Status
ACTIVE

Related Recalls

HIGH

Fresenius Kabi Vancomycin Injection Recalled Over Sterility Concerns

Fresenius Kabi Compounding recalled its vancomycin HCl injection on February 5, 2026, due to a lack of assurance of sterility. This Class II recall affects all lots distributed nationwide. Healthcare providers and consumers must stop using the product immediately.

Fresenius Kabi Compounding
Lack of
Read more
HIGH

Fresenius Kabi Compounding Issues Recall of Vancomycin Injection

Fresenius Kabi Compounding recalled 1,578 bags of vancomycin HCl injection on February 5, 2026. The company cited a lack of assurance of sterility as the reason for the recall. Healthcare providers and consumers should stop using the product immediately.

Fresenius Kabi Compounding
Lack of
Read more
HIGH

Pro Numb Tattoo Numbing Spray Recalled Due to cGMP Violations

Pro Numb Tattoo Numbing Spray was recalled on February 2, 2026 due to cGMP deviations. The product, containing 4% lidocaine, is distributed by Pro Numb Tattoo Numbing Spray LLC. Consumers should stop using it immediately and contact the company for further guidance.

PRO NUMB SENSITIVE SKIN
cGMP deviations
Read more